Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models

As a novel orally active multitarget small molecule inhibitor, CS2164 has shown broad antitumor activities against several human tumor xenograft models in immune-compromised mice. However, the ability of CS2164 to modulate antitumor immunity in an immune-competent mouse tumor model remains undefined...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Drugs
Main Authors: Zhou, You, Fu, Chao, Kong, Yidi, Pan, Desi, Wang, Yanan, Huang, Shengjian, Li, Zhibin, Ning, Zhiqiang, Lu, Xianping, Shan, Song, Xin, Lijun
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Preclinical Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749973/
https://ncbi.nlm.nih.gov/pubmed/30998512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000791
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados